Sort
64,565 grants matching “drug discovery”
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing
$1,174,809Jonathan Himmelfarb · University Of Washington · UH3 · FY2021 · TR
SMARTT COORDINATING CENTER
$1,174,776Diane Severynse · Research Triangle Institute · N01 · FY2014 · HL
Integrated Technologies for Polymeric Biomaterials, RESBIO
$1,174,662Joachim B. Kohn · Rutgers, The State Univ Of N.J. · P41 · FY2014 · EB
Development of a Novel Lead Series Against Category A & B Bacterial Pathogens
$1,174,338Terry L Bowlin · Microbiotix, Inc · U01 · FY2012 · AI
Monoclonal Immunoprotectants for Select Agents Toxins (Mab-SAT)
$1,174,260Larry Zeitlin · Mapp Biopharmaceutical, Inc. · U01 · FY2011 · AI
Center for Advanced Renal Microscopic Analysis
$1,174,019Bruce A Molitoris · Indiana University Indianapolis · P30 · FY2012 · DK
Biomedical Simulations Resource (BMSR)
$1,173,550David Z D'argenio · University Of Southern California · P41 · FY2009 · EB
Microphysiological systems to Advance Precision medicine for Alzheimer's Disease and Related Dementias (MAP-AD)
$1,173,352Jason Stephen Meyer · Indiana University Indianapolis · U54 · FY2025 · AG
Target ID (3 of 4)
$1,173,310Stuart L Schreiber · Broad Institute, Inc. · RL1 · FY2011 · HG
Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,173,264Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Neurodegenerative Lysosomal Storage Disorders
$1,173,256Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets
$1,172,629D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UG3 · FY2018 · DK
Microbial exploration for new antimicrobial discovery
$1,172,547Akintunde Emiola · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Project 1 - Coronavirus
$1,172,341Mark R Denison · University Of Alabama At Birmingham · U19 · FY2023 · AI
Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens
$1,171,930Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2020 · AI
Apoptosis-Based Cancer Drug Discovery
$1,171,799John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U19 · FY2006 · CA
Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults
$1,171,721Veronique Vanderhorst · Beth Israel Deaconess Medical Center · R01 · FY2025 · AG
Microenvironmental control of progenitors in organ dysfunction and repair
$1,171,517Jay W Schneider · Ut Southwestern Medical Center · U01 · FY2014 · HL
Raman Flow Cytometry for Diagnostics and Drug Discovery
$1,171,157John P Nolan · La Jolla Bioengineering Institute · R01 · FY2007 · EB
SBIR Phase II: Developing a Platform for Multiplexed Drug Profiling Using Yeast Synthetic Agglutination
$1,170,453David A Younger · A-Alpha Bio, Inc. · · FY2020 · TIP
Training/Education: Advance in Clinical Research (RMI)
$1,170,251University Of Wisconsin Madison · K12 · FY2004 · HD
Epi-seq: Multiplexed ChIP-seq for personalized medicine and drug discovery
$1,170,177Mary Anne Jelinek · Active Motif, Inc. · R44 · FY2019 · HG
Discovery of B. pseudomallei therapeutics for Biodefense
$1,170,128Donald T Moir · Microbiotix, Inc · R44 · FY2007 · AI
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center
$1,170,059Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2024 · CA
Genetics of Kidney Transplantiaion
$1,169,890Scripps Research Institute · U19 · FY2005 · AI